UPDATE 2-GlaxoSmithKline CEO Witty to bow out in March 2017

[ahlam1399]

UPDATE 2-GlaxoSmithKline CEO Witty to bow out in March 2017
* GSK to weigh internal and external candidates as new CEO (Adds analyst comment, relative performance)


http://rc.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/rc/1/rc.htm)

http://rc.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/rc/2/rc.htm)

http://rc.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/rc/3/rc.htm)


http://da.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/a2.img (http://da.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/ach.img (http://adchoice.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/ach.htm)http://pi.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/a2t.imghttp://pi2.feedsportal.com/r/247395021870/u/49/f/654213/c/35217/s/4e5272d0/sc/28/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e5272d0/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=XNYwKPmbxI8:-uaJTppzhFk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=XNYwKPmbxI8:-uaJTppzhFk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=XNYwKPmbxI8:-uaJTppzhFk:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=XNYwKPmbxI8:-uaJTppzhFk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=XNYwKPmbxI8:-uaJTppzhFk:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/XNYwKPmbxI8